MicroRNA-34a and promoter methylation contribute to peroxisome proliferator-activated receptor gamma gene expression in patients with type 2 diabetes
Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2024
DOI: 10.1016/j.dsx.2024.103156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024. Verfasst von Mona Moghadasi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; Department Clinical Biochemistry and Genetics, School…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, DNA Methylation, PPAR gamma, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Lorestan University of Medical Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
AIMS: This study aimed to investigate the roles of DNA methylation and miR-34a in the regulation of peroxisome proliferator-activated receptor gamma (PPARγ) in patients with type 2 diabetes (T2D). METHODS: We investigated the methylation status of four regions of the PPARγ promoter and PPARγ expression in a panel of 84 T2D patients using methylation-specific PCR (MSP) and RT-qPCR, respectively. Moreover, we quantified DNA methyltransferases (DNMTs) expression and global DNA methylation levels by RT-qPCR and ELISA, respectively. We measured the expression levels of miR-34a and protein expression of PPARγ by stem-loop RT-qPCR and ELISA, respectively. RESULTS: We found significant DNA hypermethylation in the R2 and R3 regions of the PPARγ promoter in people with diabetes. Functionally, this was associated with a significant reduction in PPARγ expression. In addition, we observed a significant increase in 5-methylcytosine levels in people with diabetes. A marked increase in circulating miR-34a in the early stages of T2D (up to 10 years) and a significant decrease in circulating miR-34a with increasing diabetes duration from 10 years after the onset of diabetes. Interestingly, upregulation of DNA methyltransferases 1 (DNMT1), DNMT3A, and DNMT3B was observed in people with diabetes, and the average expression of DNMTs was negatively correlated with circulating miR-34a levels. In contrast, the serum protein level of PPARγ, a direct target of miR-34a, increased considerably with diabetes duration and showed a negative correlation with circulating miR-34a, cholesterol, triglyceride, and low-density lipoprotein. CONCLUSION: PPARγ promoter hypermethylation and miR-34a upregulation are associated with T2D pathogenesis through PPARγ dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; Department Clinical Biochemistry and Genetics, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Ir…
- Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran; Department of Biostatistics and Epidemiology, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad,…
- Department of Internal Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
- Department Clinical Biochemistry and Genetics, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran; Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. Elect…
Förderung
- Lorestan University of Medical Sciences
Zitieren
APA
Moghadasi, M., Taherimoghaddam, M., Babaeenezhad, E., Birjandi, M., Kaviani, M., & Moradi Sarabi, M. (2024). MicroRNA-34a and promoter methylation contribute to peroxisome proliferator-activated receptor gamma gene expression in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2024.103156
Vancouver
Moghadasi M, Taherimoghaddam M, Babaeenezhad E, Birjandi M, Kaviani M, Moradi Sarabi M. MicroRNA-34a and promoter methylation contribute to peroxisome proliferator-activated receptor gamma gene expression in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024. doi:10.1016/j.dsx.2024.103156
BibTeX
@article{Moghadasi2024,
author = {Moghadasi, Mona and Taherimoghaddam, Mozhgan and Babaeenezhad, Esmaeel and Birjandi, Mehdi and Kaviani, Mozhgan and Moradi Sarabi, Mostafa},
title = {MicroRNA-34a and promoter methylation contribute to peroxisome proliferator-activated receptor gamma gene expression in patients with type 2 diabetes},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
year = {2024},
doi = {10.1016/j.dsx.2024.103156}
}
EUVIMED